Ongoing Clinical Studies

Filter By State

Filter By Disease Site

Name Physician(s)
Bladder Cancer

A Phase II Protocol for Patients with Stage T1 Bladder Cancer to Evaluate Selective Bladder Preserving Treatment by Radiation Therapy Concurrent with Radiosensitizing Chemotherapy Following a Thorough Transurethral Surgical Re-Staging

John Vito Antonucci, MD
Steven E. Finkelstein, MD
Jeffrey D. Forman, MD
Michael I. Ghilezan, MD
Larry L. Kestin, MD
Alvaro A. Martinez, MD
Frank A. Vicini, MD
Breast Cancer

Employing objective methods to compare cosmetic outcomes between minority and non-minority women after breast conservation therapy.

Sophia Edwards-Bennett, MD, PhD, DABR®

Larry L. Kestin, MD

A Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Phase 2 Study of the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of RTA 408 Lotion in the Treatment of Patients at Risk

Sophia Edwards-Bennett, MD, PhD, DABR®

Prospective Neo-Adjuvant REGISTRY Trial Linking MammaPrint, Subtyping and Treatment Response: Neoadjuvant Breast Registry - Symphony Trial

Steven E. Finkelstein, MD
David T. Rock, MD

Prospective Registry Of MammaPrint in breast cancer patients with an Intermediate recurrence Score (PROMIS)

David T. Rock, MD

ASBrS Nipple Sparing Mastectomy Registry

David T. Rock, MD

A Randomized Phase III Trial of the Value of Early Local Therapy for the Intact Primary Tumor in Patients with Metastatic Breast Cancer

Ron R. Allison, MD
John Vito Antonucci, MD
Warren R. Amos, MD, FRS
Cynthia A. Ballenger, MD
Ahmed E. Ezz, MD, MBBCh, FRCP-C
Steven E. Finkelstein, MD
Jeffrey D. Forman, MD
Dwight L. Fitch, MD
Michael I. Ghilezan, MD
Andrej V. Hnatov, MD
Larry L. Kestin, MD
David C. Khan, MD
Alvaro A. Martinez, MD
Kay T. Miller, MD
Daniel C. Schiffner, MD
Sayana Shah, MD
James H. Stevens, MD
John E. Sylvester, MD
Frank A. Vicini, MD